ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 102817 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 102817; 2) Community: the network communities that were significantly associated with the response to NSC 102817; 3) Molecule: the relationships between components within communities and NSC 102817; 4) MDR: the compounds that were significantly associated with the NSC 102817.

NSC Compound Enrichment Correlation
NSC 749025 Null 0.0430277102950697 0.13039101
NSC 750332 4-(4-chlorophenyl)-1-3-[(E)-3-(3,4,5-trimethoxyphenyl)-2-propenoyl]phenyl-2,3-dihydro-1H-2-imidazolone 0.0430277102950697 0.32660647
NSC 753221 3-Hydroxy-10-fluoro-5.6-dihydro-6-imino-isoindolo[2,1a]quinoxaline 0.0430277102950697 0.19608335
NSC 753222 3-Hydroxy-5,6-dihydro-6-imino-8,9-dimethylisoindolo-[2,1-a]quinoxaline 0.0430277102950697 0.2667131
NSC 87086 Null 0.0430277102950697 -0.25784849
NSC 200692 Aspiculamycin hydrochloride 0.0454469012959163 -0.30314664
NSC 294600 MELAMPODININ 0.0454469012959163 0.73711859
NSC 354258 Null 0.0454469012959163 0.3362867
NSC 625498 4-Morpholinecarbodithioic acid, antimony complex 0.0454469012959163 0.36764584
NSC 632790 Platinum, dichloro(quinoline-N)[sulfinylbis(methane)-S]-, (SP-4-1) 0.0454469012959163 0.77823831
Total:136  Current:131    [First] [Prev] [Next] [Last]